"Active Surveillance & Beyond" A Webinar Series

Pioneer Speaks About Active Surveillance for Prostate Cancer
Dr. Peter Carroll launches webinar series July 30
 

AnCan and Us Too International, sponsors of support groups for men with prostate cancer, today announced a series of four webinars, Active Surveillance & Beyond, aimed at men on or considering active surveillance (AS) for low- and intermediate-risk prostate cancer in place of aggressive therapy.

Dr. Peter Carroll, one of the pioneers of the AS approach of monitoring these cancers, will kick off the series on July 30 at 8 p.m. Eastern. His topic is “The Past, Present, and Future of Active Surveillance.” Dr. Carroll stepped down earlier this year as Chair of Urology at the University of California, San Francisco, but remains an active researcher.

ASPI (Active Surveillance Patients Internationa),  PCRI (Prostate Cancer Research Institute), and ZERO - The End of Prostate Cancer co-sponsor the webinars.

To register for the July 30 webinar with Dr. Carroll, go to
https://attendee.gotowebinar.com/register/8711469517744476428

To submit questions ahead of the July 30 session or for information, write to joeg@ancan.org

Other webinars in the AS & Beyond series are :
 

• September 29. Dr. Brian Helfand, Division Chief of Urology, NorthShore University 
  HealthSystem, Glenview, Illinois, will discuss where things stand and where they are 
  heading with genomic testing in decision-making for AS.

• November 30. Dr. Antonio Westphalen, Chief of Abdominal Imaging, University of Washington at Seattle, will discuss his research on the value of monitoring men on AS with multiparametric MRIs and how to find the best radiologist to read your MRI.

• December 30. Dr. Jonathan Epstein, Chair of Urological Pathology, The JohnsHopkins Medical Institutions in Baltimore, will speak about critical issues of grading prostate cancer for patients considering AS.

#AS&Beyond #activesurveillance  #Gleason6 #ProstateCancer